Ovarian Cancer
Ovarian cancer prognosis linked to polymorphism in matrix metalloproteinase-1
Published in Cancer Weekly, May 1st, 2006
According to recent research from Austria, "The enzyme matrix metalloproteinase-1 (MMP-1) is involved in ovarian carcinogenesis. A common guanine insertion-deletion promoter polymorphism within the gene encoding MMP-1 (MMP1) has been suggested to be a candidate gene for ovarian cancer."
"We investigated whether this common polymorphism can also serve as independent prognostic parameter in a large series of affected women. The MMPI promoter polymorphism was examined in 151 Caucasian patients with epithelial ovarian cancer using polymerase...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-05-01)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer nomogram for predicting nonsentinel lymph node metastases validated - Prostate Cancer
Prostate cancer apoptosis induced by berberine - Rectal Cancer
Low rectal cancer staging improved with pretreatment FDG-PET-CT - Testicular Cancer
Predictors of testicular cancer quality of life investigated - Adenomas
Aldosterone-producing adenomas have elevated levels of luteinizing hormone receptor expression - Adrenal Adenoma & Myelolipoma
Patient with adrenal adenoma plus myelolipoma relieved of hypertension by adrenalectomy - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
